These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21335570)

  • 21. Cognitive impairments in advanced PD without dementia.
    Green J; McDonald WM; Vitek JL; Evatt M; Freeman A; Haber M; Bakay RA; Triche S; Sirockman B; DeLong MR
    Neurology; 2002 Nov; 59(9):1320-4. PubMed ID: 12427877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).
    Song IU; Kim JS; Park IS; Kim YD; Cho HJ; Chung SW; Lee KS
    Arch Gerontol Geriatr; 2013; 57(3):288-91. PubMed ID: 23706974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical comparison of dementia in Parkinson's and Alzheimer's disease.
    Marschall I; Dal-Bianco P; Maly J; Auff E; Hufgard J; Mraz M; Deecke L
    J Neural Transm Suppl; 1991; 33():81-92. PubMed ID: 1661322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease.
    Spalletta G; Robinson RG; Cravello L; Pontieri FE; Pierantozzi M; Stefani A; Long JD; Caltagirone C; Assogna F
    J Neurol; 2014 Jun; 261(6):1126-32. PubMed ID: 24695996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neuropsychological comparison of demented and nondemented patients with Parkinson's disease.
    Zakzanis KK; Freedman M
    Appl Neuropsychol; 1999; 6(3):129-46. PubMed ID: 10497689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG; Stebbins GT; Blasucci LM
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Hely MA; Morris JG; Reid WG; Trafficante R
    Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep spindles in Parkinson's disease may predict the development of dementia.
    Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
    Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side and type of motor symptom influence cognition in Parkinson's disease.
    Katzen HL; Levin BE; Weiner W
    Mov Disord; 2006 Nov; 21(11):1947-53. PubMed ID: 16991155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequency and associated risk factors for dementia in patients with Parkinson's disease.
    Marder K; Tang MX; Cote L; Stern Y; Mayeux R
    Arch Neurol; 1995 Jul; 52(7):695-701. PubMed ID: 7619026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.